CA2370489A1 - 49 proteines humaines secretees - Google Patents

49 proteines humaines secretees Download PDF

Info

Publication number
CA2370489A1
CA2370489A1 CA002370489A CA2370489A CA2370489A1 CA 2370489 A1 CA2370489 A1 CA 2370489A1 CA 002370489 A CA002370489 A CA 002370489A CA 2370489 A CA2370489 A CA 2370489A CA 2370489 A1 CA2370489 A1 CA 2370489A1
Authority
CA
Canada
Prior art keywords
human
seq
sequence
polypeptide
soares
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002370489A
Other languages
English (en)
Inventor
Steven M. Ruben
George Komatsoulis
Craig A. Rosen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2370489A1 publication Critical patent/CA2370489A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

L'invention concerne des nouvelles protéines humaines sécrétées ainsi que des acides nucléiques isolés, contenant les régions codantes des gènes codant pour lesdites protéines. Elle porte également sur des vecteurs, sur des cellules hôtes, sur des anticorps et sur des méthodes de recombinaison pour la production de protéines humaines sécrétées. Elle se rapporte aussi à des méthodes diagnostiques et thérapeutiques utiles pour le traitement de maladies, de troubles et/ou d'états liés auxdites protéines humaines sécrétées.
CA002370489A 1999-04-09 2000-04-06 49 proteines humaines secretees Abandoned CA2370489A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US12869499P 1999-04-09 1999-04-09
US60/128,694 1999-04-09
US17693100P 2000-01-20 2000-01-20
US60/176,931 2000-01-20
PCT/US2000/009071 WO2000061629A1 (fr) 1999-04-09 2000-04-06 49 proteines humaines secretees

Publications (1)

Publication Number Publication Date
CA2370489A1 true CA2370489A1 (fr) 2000-10-19

Family

ID=26826853

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002370489A Abandoned CA2370489A1 (fr) 1999-04-09 2000-04-06 49 proteines humaines secretees

Country Status (5)

Country Link
EP (1) EP1175439A4 (fr)
JP (1) JP2003501011A (fr)
AU (1) AU4200900A (fr)
CA (1) CA2370489A1 (fr)
WO (1) WO2000061629A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7985843B2 (en) 1999-09-10 2011-07-26 Corixa Corporation Compositions and methods for the therapy and diagnosis of ovarian cancer

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6710170B2 (en) 1999-09-10 2004-03-23 Corixa Corporation Compositions and methods for the therapy and diagnosis of ovarian cancer
EP1280937A2 (fr) * 2000-04-26 2003-02-05 Millennium Pharmaceuticals, Inc. Methodes et compositions destinees au diagnostic et au traitement des maladies cardio-vasculaires et tumorigenes a l'aide de 4941
AU6531101A (en) * 2000-06-02 2001-12-17 Genentech Inc Secreted and transmembrane polypeptides and nucleic acids encoding the same
JP2008289482A (ja) * 2000-11-14 2008-12-04 Corixa Corp 卵巣癌の治療および診断のための組成物および方法
US20030120040A1 (en) 2001-06-29 2003-06-26 Genentech, Inc. Secreted and Transmembrane polypeptides and nucleic acids encoding the same
WO2003020307A1 (fr) * 2001-08-31 2003-03-13 The General Hospital Corporation Genes induits par la proteine 2 morphogenique osseuse et polypeptides, utilisations de ceux-ci dans des techniques diagnostiques et therapeutiques
US20050123925A1 (en) 2002-11-15 2005-06-09 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
EP1771474B1 (fr) 2004-07-20 2010-01-27 Genentech, Inc. Inhibiteurs de la proteine 4 de type angiopoietine, combinaisons correspondantes et leur utilisation
AU2005269758B2 (en) 2004-07-20 2011-11-03 Genentech, Inc. Compositions and methods of using angiopoietin-like 4 protein
US8604185B2 (en) 2004-07-20 2013-12-10 Genentech, Inc. Inhibitors of angiopoietin-like 4 protein, combinations, and their use
AR059900A1 (es) 2006-03-17 2008-05-07 Genentech Inc Anticuerpos anti-tat226 e inmunoconjugados
AU2008218199B2 (en) 2007-02-22 2013-10-31 Genentech, Inc. Methods for detecting inflammatory bowel disease
JP2012515548A (ja) * 2009-01-21 2012-07-12 マサチューセッツ インスティテュート オブ テクノロジー 単一細胞の細胞傷害性を査定するための組成物および方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5654139A (en) * 1994-09-21 1997-08-05 The United States Of America As Represented By The Department Of Health And Human Services Allelic variation of the serotonin 5HT2c receptor

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7985843B2 (en) 1999-09-10 2011-07-26 Corixa Corporation Compositions and methods for the therapy and diagnosis of ovarian cancer

Also Published As

Publication number Publication date
EP1175439A1 (fr) 2002-01-30
AU4200900A (en) 2000-11-14
WO2000061629A1 (fr) 2000-10-19
EP1175439A4 (fr) 2002-10-09
JP2003501011A (ja) 2003-01-14

Similar Documents

Publication Publication Date Title
CA2385475A1 (fr) 18 proteines secretees humaines
CA2382185A1 (fr) 48 proteines secretees humaines
CA2383041A1 (fr) 49 proteines secretees humaines
CA2370489A1 (fr) 49 proteines humaines secretees
CA2368927A1 (fr) Quarante-cinq proteines humaines secretees
CA2387696A1 (fr) 48 proteines humaines secretees
CA2365223A1 (fr) Proteines humaines secretees (46)
CA2370767A1 (fr) 49 proteines humaines secretees
CA2368281A1 (fr) 50 proteines humaines secretees
CA2368467A1 (fr) 50 proteines humaines secretees
CA2365522A1 (fr) 48 proteines secretees humaines
CA2368302A1 (fr) 49 proteines secretees par un etre humain
CA2364635A1 (fr) 47 proteines humaines secretees
CA2370441A1 (fr) 50 proteines humaines secretees
CA2371172A1 (fr) 50 proteines humaines secretees
CA2365247A1 (fr) Proteines humaines secretees (49)
CA2368374A1 (fr) 47 proteines humaines secretees
CA2370189A1 (fr) 48 proteines secretees humaines
CA2364650A1 (fr) Proteines humaines secretees (50)
CA2368442A1 (fr) 48 proteines humaines secretees
CA2382743A1 (fr) 48 proteines secretees humaines
CA2365905A1 (fr) 48 proteines humaines secretees
CA2368916A1 (fr) 49 proteines humaines secretees
CA2368210A1 (fr) Cinquante proteines humaines secretees
CA2367620A1 (fr) Proteines humaines secretees (47)

Legal Events

Date Code Title Description
FZDE Dead